SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-17-027498
Filing Date
2017-05-15
Accepted
2017-05-15 16:25:44
Documents
34
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v466491_10q.htm 10-Q 198478
2 EXHIBIT 31.1 v466491_ex31-1.htm EX-31.1 10793
3 EXHIBIT 31.2 v466491_ex31-2.htm EX-31.2 11518
4 EXHIBIT 32.1 v466491_ex32-1.htm EX-32.1 4351
5 EXHIBIT 32.2 v466491_ex32-2.htm EX-32.2 4289
  Complete submission text file 0001144204-17-027498.txt   1573428

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT accp-20170331.xml EX-101.INS 262666
7 XBRL TAXONOMY EXTENSION SCHEMA accp-20170331.xsd EX-101.SCH 13970
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE accp-20170331_cal.xml EX-101.CAL 32152
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE accp-20170331_def.xml EX-101.DEF 65434
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE accp-20170331_lab.xml EX-101.LAB 215626
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE accp-20170331_pre.xml EX-101.PRE 134031
Mailing Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219
Business Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219 2149055100
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15771 | Film No.: 17844610
SIC: 2834 Pharmaceutical Preparations